Data as of Dec 17
| +0.03 / +1.23%|
The 3 analysts offering 12-month price forecasts for IntelliPharmaCeutics International Inc have a median target of 8.00, with a high estimate of 11.00 and a low estimate of 7.00. The median estimate represents a +225.20% increase from the last price of 2.46.
The current consensus among 3 polled investment analysts is to Buy stock in IntelliPharmaCeutics International Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.